Prescription drug · ANDA
Etomidate (etomidate injection) NDC 72266-147
Etomidate 2 mg/mL · Solution · Intravenous · Fosun Pharma USA Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 72266-147-10 | 72266014710 | 10 VIAL in 1 CARTON (72266-147-10) / 20 mL in 1 VIAL (72266-147-01)Marketed from Sep 3, 2019 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Etomidate
- Generic name (nonproprietary)
- etomidate injection
- Active ingredients
- Etomidate — 2 mg/mL
- Dosage form
- Solution
- Route
- Intravenous
- Labeler
- Fosun Pharma USA Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 209058
- Marketing start
- Listing expires
- Other FDA classes
- General Anesthesia (Physiologic effect)
- Identifiers
- Product ID 72266-147_2b365133-b609-3285-e063-6394a90a69a6SPL ID 2b365133-b609-3285-e063-6394a90a69a6SPL set ID 8b6c54d8-3f3f-4290-841c-976bea01086fRxCUI 1654006, 1654008UNII Z22628B598UPC 0372266147103, 0372266147011, 0372266146106
- Pharmacologic class
- General Anesthetic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N472266014710followed by a unit qualifier and the quantityPackage 72266-0147-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Etomidate Injection, USP is indicated by intravenous injection for the induction of general anesthesia. When considering use of etomidate, the usefulness of its hemodynamic properties (see CLINICAL PHARMACOLOGY ) should be weighed against the high frequency of transient skeletal muscle movements (see ADVERSE REACTIONS ). Intravenous etomidate is also indicated for the supplementation of subpotent anesthetic agents, such as nitrous oxide in oxygen, during maintenance of anesthesia for short operative procedures such as dilation and curettage or cervical conization.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 209058
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Etomidateetomidate injection | Etomidate 2 mg/mL | SolutionIntravenous | Gland Pharma Limited | 68083-235 |
| Etomidateetomidate injection | Etomidate 2 mg/mL | SolutionIntravenous | Gland Pharma Limited | 68083-234 |
| Etomidateetomidate injection | Etomidate 2 mg/mL | SolutionIntravenous | Fosun Pharma USA Inc | 72266-146 |